Results 91 to 100 of about 1,533 (110)

Evolution of Self-reported Neuropsychiatric Symptoms After Switching from Dolutegravir/Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide: Results from the Randomized DOBINeuro Trial. [PDF]

Infect Dis Ther
Rossetti B, Ferrara M, Taramasso L, Bai F, Lombardi F, Ciccarelli N, Durante M, Alladio F, Bonazza F, Rancan I, Montagnani F, Di Biagio A, Monforte AD, Zazzi M, Fabbiani M, for DOBINeuro study group.   +15 more
europepmc   +1 more source

Rhabdomyolysis in Acute HIV Infection. [PDF]

Cureus
Mekonen YF, Perez MV, Tole MC, Redondo O, Ali M.   +4 more
europepmc   +1 more source

Improved Automated Radiosynthesis of [¹⁸F]Dolutegravir: Toward Clinical Applications. [PDF]

ACS Omega
Huvelle S, Pinon A, Coulon C, Bonasera T, Chapon C, Naninck T, Le Grand R, Parry CM, Kuhnast B, Caillé F.   +9 more
europepmc   +1 more source

Amiodarone Therapy: Updated Practical Insights. [PDF]

J Clin Med
Șorodoc V, Indrei L, Dobroghii C, Asaftei A, Ceasovschih A, Constantin M, Lionte C, Morărașu BC, Diaconu AD, Șorodoc L.   +9 more
europepmc   +1 more source

Advances in humanoid organoid-based research on inter-organ communications during cardiac organogenesis and cardiovascular diseases. [PDF]

J Transl Med
Ni B, Ye L, Zhang Y, Hu S, Lei W.
europepmc   +1 more source

<i>N</i>-Substituted Bicyclic Carbamoyl Pyridones: Integrase Strand Transfer Inhibitors that Potently Inhibit Drug-Resistant HIV-1 Integrase Mutants. [PDF]

ACS Infect Dis
Mahajan PS, Smith SJ, Li M, Craigie R, Hughes SH, Zhao XZ, Burke TR.   +6 more
europepmc   +1 more source

In Vitro Anti-HIV-1 Activity of Fucoidans from Brown Algae. [PDF]

Mar Drugs
Nosik MN, Krylova NV, Usoltseva RV, Surits VV, Kireev DE, Shchelkanov MY, Svitich OA, Ermakova SP.   +7 more
europepmc   +1 more source

Immunological Enigma: A Case Report of COVID-19 Survival in a Patient With Human Immunodeficiency Virus, Hepatitis C Virus, and Tuberculosis Co-infection. [PDF]

Cureus
Bozhkova M, Petrov S, Velyanova T, Stoycheva M, Murdjeva M.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Biorelevant in vitro Tools and in silico Modeling to Assess pH-Dependent Drug-drug Interactions for Salts of Weak Acids: Case Example Potassium Raltegravir

Journal of Pharmaceutical Sciences, 2022
Early assessment of pH-dependent drug-drug-interactions (DDIs) for salts of poorly soluble weakly acidic compounds offers various advantages for patient safety, the pharmaceutical industry, and regulatory bodies. Biorelevant media and tests reflecting physiological changes during acid-reducing agent (ARA) co-administration can be used to explore and ...
Andrea Moir, Jennifer B. Dressman, Jennifer B. Dressman, Eva Karlsson, Domagoj Segregur, James Mann   +5 more
openaire   +2 more sources

Raltegravir Potassium

Hospital Pharmacy, 2008
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to your Pharmacy & Therapeutics Committee. Subscribers also receive monthly 1-page summary monographs on the agents that are useful for agendas and pharmacy/
Dennis J. Cada, Danial E. Baker, Terri Levien   +2 more
openaire   +2 more sources